DUBLIN, Ireland--(BUSINESS WIRE)--Mar. 14, 2014--
plc (NYSE: COV) will report second-quarter fiscal 2014 results on April
25. The company will host a conference call for investors at 8:30 a.m.
ET. The call can be accessed in the following ways:
Via webcast at Covidien’s website: http://investor.covidien.com
By telephone: For both “listen-only” participants and those
participants who wish to take part in the question-and-answer portion
of the call, the telephone dial-in number in the U.S. is 866-318-8619.
For participants outside the U.S., the dial-in number is 617-399-5138.
The access code for all callers is 52526602.
Through an audio replay: A replay of the conference call will be
available beginning at 11:30 a.m. ET on April 25 and ending at 5 p.m.
on May 2. The dial-in number for U.S. participants is 888-286-8010.
For participants outside the U.S., the replay dial-in number is
617-801-6888. The replay access code for all callers is 14785021.
The company will issue a news release announcing financial results for
the fiscal second quarter on April 25, prior to the conference call.
Covidien is a leading global healthcare products company that creates
innovative medical solutions for better patient outcomes and delivers
value through clinical leadership and excellence. Covidien develops,
manufactures and sells a diverse range of industry-leading medical
device and supply products. With 2013 revenue of $10.2 billion, Covidien
has more than 38,000 employees worldwide in more than 70 countries, and
its products are sold in over 150 countries. Please visit www.covidien.com
to learn more about our business.
Source: Covidien plc
Peter Lucht, 508-452-4168
Lannum, CFA, 508-452-4343